Type IV secretion systems (T4SSs) are multiprotein complexes that transport effector proteins and protein–DNA complexes through bacterial membranes to the extracellular milieu or directly into the cytoplasm of other cells. Many bacteria of the family Xanthomonadaceae, which occupy diverse environmental niches, carry a T4SS with unknown function but with several characteristics that distinguishes it from other T4SSs. Here we show that the Xanthomonas citri T4SS provides these cells the capacity to kill other Gram-negative bacterial species in a contact-dependent manner. The secretion of one type IV bacterial effector protein is shown to require a conserved C-terminal domain and its bacteriolytic activity is neutralized by a cognate immunity protein whose 3D structure is similar to peptidoglycan hydrolase inhibitors. This is the first demonstration of the involvement of a T4SS in bacterial killing and points to this special class of T4SS as a mediator of both antagonistic and cooperative interbacterial interactions.
Bacterial cells are continuously interacting with other bacterial and eukaryotic cells in a relentless battle for survival. These interactions have driven the evolution of several mechanisms by which they quickly deploy proteinaceous and nucleic acid effectors that manipulate the behaviour of the target organism, often resulting in growth inhibition or death1,2,3,4,5,6. Distinct among these mechanisms are the type III, type IV and type VI secretion systems (T3SS, T4SS and T6SS, respectively) that are all capable of transferring proteins, and in the case of the T4SS, protein–DNA complexes, directly into neighbouring cells in a contact-dependent manner1,2,3. All three of these systems have been shown to be able to inject virulence factors into eukaryotic hosts, but only the T6SSs have been shown to deliver lethal toxins into bacterial cells7.
T4SSs are perhaps the most versatile of the macromolecular transport systems, being essential for host colonization by many medically important microbes8,9,10,11,12,13, the horizontal transfer of genetic material between bacteria and from bacteria to plants2 as well as the special cases of the Helicobacter pylori DNA uptake14 and Neisseria gonorrhoeae DNA release15 systems. The prototypical T4SS is that of the plant pathogen Agrobacterium tumefaciens that uses its Vir system to cause tumours in most dicotyledonous species16. T4SSs are generally made up of a core set of 12 proteins, named VirB1–VirB11 plus VirD4 with a structural organization that is only now being elucidated: (i) a set of three cytoplasmic ATPases (VirB4, VirB11 and VirD4) that energize secretion; (ii) a periplasmic core complex made up of 14 repeats of a VirB7–VirB9–VirB10 trimer, in which VirB10 inserts into both inner and outer membranes and VirB7 is an outer membrane lipoprotein; (iii) an inner membrane complex that includes VirB3, VirB6 and VirB8; (iv) an extracellular pilus formed by VirB2 and VirB5; and (v) the periplasmic transglycosylase VirB1 (refs 2, 17, 18, 19).
Many bacteria of the family Xanthomonadaceae, which occupy diverse environmental niches, carry a T4SS with unknown function but with several characteristics that distinguishes it from other T4SSs20,21. One of these distinguishing features is that the Xanthomonas citri (Xac) VirD4 protein (VirD4XAC2623), a homologue of the coupling protein that recruits effectors to the T4SS for secretion2, interacts with a set of uncharacterized Xanthomonas VirD4-interacting proteins (XVIPs) that all contain a conserved C-terminal domain termed XVIPCD (XVIP-conserved domain)20. In this study, we show that these XVIPs are toxins secreted by the Xanthomonas T4SS, that secretion is dependent on the XVIPCD and that this special T4SS is used by Xanthomonas to kill other bacterial cells, thereby providing a competitive growth advantage in mixed bacterial communities.
A hypothesis for a new physiological role for a T4SS
The Xac XVIPs are highly diverse in size and architecture and lack a canonical signal sequence. Six Xac XVIPs (XAC0466, XAC0574, XAC1918, XAC2609, XAC2885 and XAC3634) are predicted to act within the periplasm as peptidoglycan (PG)-binding proteins, PG glycohydrolases, lytic transglycosylases, PG peptidases or lipases (Fig. 1a). Furthermore, the genes of these proteins, plus one other containing an HExxH metallopeptidase motif (XAC0096), are found downstream to, and potentially co-transcribed with, genes that code for proteins with unknown functions with predicted lipoprotein signal peptides that are expected to localize them within the bacterial periplasm (Fig. 1). One XVIP (XAC2609) has a complete PG-binding domain (residues 219–280) and a region (residues 30–120) with similarity to the catalytic region of proteins of glycoside hydrolase family 19 (GH19) that possess chitinase- or lysozyme-like activities22 (Fig. 1). XAC2609 has been shown to interact with the putative periplasmic lipoprotein XAC2610 and both are coded by genes within the Xac chromosomal T4SS vir locus20. These characteristics are very similar to those observed for certain T6SS effectors with hydrolytic activities against conserved PG and phospholipid components of the bacterial cell wall and their cognate immunity proteins23,24. On the basis of these observations, one hypothesis is that the Xac T4SS could secrete toxins participating in toxin–immunity protein systems.
XAC2609 lyses PG and XAC2610 is its inhibitor
To test the above hypothesis, we performed a set of in vitro experiments to determine whether XAC2609 has the predicted lysozyme-like activity. Purified recombinant XAC2609 is able to degrade PG from the Gram-positive Micrococcus luteus (Fig. 2a), reduces the optical density and introduces a marked lag in the growth curve of Bacillus subtilis cultures (Fig. 2b), and results in B. subtilis cell lysis (Fig. 2d). These activities are maintained in an XAC2609 fragment lacking the XVIPCD (XAC2609(1–308); Fig. 2a) but are not observed when using a mutant XAC2609(1–308) in which glutamic acid 48 within the predicted active site of the GH19 domain was changed to alanine (Fig. 2a,e). We observed similar lytic activity against PG (Fig. 2a) and B. subtilis (Fig. 2g) for a second XVIP, XAC0466, that has a domain architecture similar to XAC2609 plus a PG amidase domain (Fig. 1a). Furthermore, the XAC2609 lytic activity is inhibited by the addition of XAC2610 (Fig. 2a,b and f). XAC2610 is a specific inhibitor of XAC2609 since it was not able to inhibit the lytic activities of XAC0466 or hen egg white lysozyme (Fig. 2a). We also observed that XAC2609 and XAC2610 can be co-immunoprecipitated from Xac cells (Supplementary Fig. 1a) and that XAC2610 interacts with the catalytic XAC2609 N-terminal domain but not with the XVIPCD domain in vitro (Supplementary Fig. 1b). Due to these characteristics, we will therefore now refer to XAC2609 as X-TfeXAC2609 (for Xanthomonadaceae-T4SS effector) and to XAC2610 as X-TfiXAC2610 (for Xanthomonadaceae-T4SS immunity protein).
X-TfiXAC2610 structure is similar to PG hydrolase inhibitors
The X-TfiXAC2610 protein does not share sequence similarity with any proteins of known function. We therefore determined the crystal structure of X-TfiXAC2610(55–267) (a fragment lacking the signal peptide, lipobox lipidation signal and a predicted unstructured region). Details of X-TfiXAC2610(55–267) crystallization, data collection and refinement are found in the Methods section and Supplementary Table 1. X-TfiXAC2610 has an N-terminal modified β-sandwich fold that includes a conserved integrin-like Ca2+-binding loop and an intramolecular disulfide bond, connected via a single α-helix to a C-terminal domain made up of an uncommon single-layer six-stranded antiparallel β-sheet (Fig. 3a). A more detailed description of the X-TfiXAC2610 structure, including the Ca2+-binding loop and its semblance to a β-propeller fragment, is presented in Supplementary Fig. 2. Supplementary Figure 3 presents small-angle X-ray scattering data that is consistent with a monomeric structure in solution. What is most interesting about the X-TfiXAC2610 structure is that among its closest topological homologues are the periplasmic I-type lysozyme inhibitor PliI25,26 (Fig. 3b) and the P. aeruginosa immunity protein Tsi1 (Fig. 3c) that inhibits the lytic PG DL-endopeptidase activity of its cognate T6SS effector protein Tse1 (refs 7, 27; see also Supplementary Fig. 4). This topological similarity includes the superposition of the ion-binding sites of the X-TfiXAC2610 and PliI proteins (Fig. 3d; Supplementary Fig. 4a). The above in vitro and structural results show that X-TfiXAC2610 is in fact the cognate immunity protein of the X-TfeXAC2609 PG hydrolase toxin.
X-Tfe secretion is T4SS dependent and requires a XVIPCD
We next tested whether X-TfeXAC2609 is secreted in a manner dependent on the Xac T4SS. For this, we employed Xac ΔvirD4 and ΔvirB7 mutants, both of which are expected to abolish secretion of all T4SS substrates since VirD4 is the coupling protein required for recognition of T4SS substrates2 and deletion of the Xac virB7 gene results in the disappearance of not just VirB7 but also VirB9 and VirB10 (ref 21), the principal components of the T4SS core complex28. Fig. 4a (top row) and Fig. 4b show that when Xac cells are spotted on nitrocellulose filters layered on Luria-Bertani (LB) agar plates, allowed to grow for 12 h and the cells washed away, we could not detect any secreted X-TfeXAC2609 bound to the membrane since the background immunofluorescence signals of all Xac strains alone are the same as that observed for the Δxac2609 mutant. However, extracellular X-TfeXAC2609 is detected when wild-type (WT) Xac cells are mixed with an equal number of E. coli cells before spotting (Fig. 4a, bottom row and Fig. 4b). Moreover, E. coli-induced X-TfeXAC2609 secretion is abolished in the ΔvirD4 and ΔvirB7 strains and restored when plasmids for expression of VirD4 or VirB7 proteins are introduced in these strains (Fig. 4a,b). These results show that X-TfeXAC2609 is secreted by Xac on contact with E. coli cells in a T4SS-dependent manner. X-TfeXAC2609 secretion is dependent on its XVIPCD since extracellular X-TfeXAC2609 could only be detected in the experiments using a Xac Δxac2609 mutant carrying a plasmid expressing full-length X-TfeXAC2609 but not in mutant strains carrying empty plasmid or a plasmid that directs the expression of an X-TfeXAC2609 fragment lacking the XVIPCD (Fig. 4a,b). Detection of extracellular X-TfeXAC2609 in these experiments is not due to E. coli-induced Xac lysis since all Xac strains (except the uncomplemented Δxac2609 mutant), including both ΔvirD4 and ΔvirB7, produce intracellular X-TfeXAC2609 (Fig. 4c).
The Xac T4SS confers an advantage in growth competition experiments
We then asked whether the T4SS confers a competitive advantage to Xac in growth competition experiments against other bacterial species. While there are no significant differences in the growth curves of the Xac WT and ΔvirD4 and ΔvirB7 mutant strains in liquid culture or on semi-solid media (Supplementary Fig. 5), when Xac cells carrying a plasmid for the expression of cyan fluorescent protein (CFP) and E. coli cells expressing yellow fluorescent protein (YFP) were mixed and allowed to grow together as a co-culture on agar plates, we observed a significant increase in both the number and the size of the yellow E. coli colonies/zones in the cyan background of the Xac ΔvirB7 strain when compared with that of the Xac WT strain (Fig. 5a,b). Xac competitiveness is recovered when the VirB7 protein is expressed in the ΔvirB7 strain (Fig. 5c). The same phenomenon was observed in competition experiments using Xac ΔvirD4 and ΔvirB7 mutants expressing green fluorescent protein (GFP) and non-fluorescent E. coli (Supplementary Fig. 6a). Furthermore, after 38 h of co-culture growth, the Xac/E. coli ratio is two orders of magnitude lower when Xac ΔvirB7 strain is used, as compared with when the Xac WT strain or Xac ΔvirB7 strain carrying a plasmid for VirB7 expression are used (Fig. 5d). To further test whether T4SS mediates it effects in a contact-dependent manner, we placed a 0.2-μm pore filter between Xac and E. coli cells. Interestingly, the T4SS-dependent growth defect of Xac ΔvirB7 and ΔvirD4 mutant strains completely disappeared under this condition (Supplementary Fig. 6b), showing that direct contact is required for this T4SS function. Xac competitiveness against Chromobacterium violaceum, another Gram-negative species from a different bacterial class (Betaproteobacteria), was also observed to be T4SS dependent in the experiments similar to those shown in Fig. 5 (Supplementary Fig. 7).
The Xac T4SS mediates bacterial killing
The competitive increment conferred by the Xac T4SS could be the result of secretion of factors that inhibit the growth of competing bacterial species or that promote direct killing of targeted adjacent cells. To distinguish between these two hypotheses, we used time-lapse microscopy to observe individual cells in Xac/E. coli co-cultures. Figure 5e–g shows micrographs of single fields obtained shortly after mixing equal amounts of Xac and E. coli cells on a thin agarose surface. While we frequently observed the rapid lysis of E. coli cells that were in direct physical contact with Xac WT cells (Fig. 5e), we did not observe these events when the ΔvirB7 and ΔvirD4 strains were used (Supplementary Fig. 8). Xac killing of E. coli was restored using mutant strains carrying plasmids for VirB7 or VirD4 expression (Fig. 5f,g). Supplementary Movie 1 presents a series of images separated by 300-ms intervals that show that E. coli cell lysis is extremely rapid, with cells often bursting in a seemingly explosive manner in <1 s to a few seconds. By comparison, Xac cell lysis was very rarely observed in these experiments. The rapid and violent cell death that we observe contrasts with that which has been reported for T6SS-mediated killing by Pseudomonas aeruginosa, in which target cells change their morphology (cell rounding, blebbing and plasmolysis) over a period of many minutes before lysis29,30.
We have provided evidence that the Xac T4SS, and by extension its homologues in other Xanthomonadaceae species, target toxins (X-Tfes or XVIPs) to bacterial cells, thereby providing Xanthomonas an advantage to survive in an environment populated by a number of different bacterial species in a manner similar to that recently described for several T6SSs29,30,31,32,33. Using the presence of a XVIPCD as search criteria, we have identified 500 potential X-Tfes in the public databases, of which all but two are derived from members of the Xanthomonadaceae family (Table 1). Most species that code for a Xanthomonadaceae-like T4SS code for several X-Tfe proteins and, in most cases analysed so far, one X-Tfe gene is found next to the gene of a T4SS component with the remaining X-Tfe genes found spread throughout the genome. Many of these proteins carry domains that may work to kill or inhibit growth of other organisms. Especially abundant are lipase domains34 and domains involved in binding or modification of PG, found exclusively in bacterial cell walls35: for example, PG-binding domain 1 (ref. 36), transglycosylase SLT37, peptidase M23 (ref. 38), GH19 (refs 22, 39) and NlpC/P60 (refs 38, 40) domains (Table 1). Other examples are the Zeta toxin domain that produces an inhibitor of bacterial PG biosynthesis41, the AHH domain likely involved in killing bacteria via its putative nuclease activity42 and DUF2235 (ref. 43), a putative hydrolase recently found to be present in T6SS effectors44 (Table 1). Both Zeta toxin and AHH domains are found in toxin–antitoxin systems where they are inhibited by specific immunity proteins41,42.
It is important to note that of the 500 X-Tfes (XVIPs) analysed in Table 1, a large majority has no recognizable domain other than the C-terminal XVIPCD. Therefore, by studying the XVIP repertoire, we can reasonably expect the number of activities of this newly characterized T4SS and its effectors to expand. The proposed general bacterial killing function for a large number of Xanthomonadaceae-T4SS effectors may have interesting biotechnological applications that lead to new drug targets and ways of fighting other pathogenic bacteria that cause disease in humans and plants. Furthermore, we speculate that some X-Tfes could provide defence against eukaryotic microbes that prey on Xanthomonads.
Finally, Ho et al.45 recently showed that P. aeruginosa uses its T6SS to attack neighbouring cells carrying a mating pair formation T4SS encoded by a conjugative plasmid. The initial speculation was that this T4SS-induced T6SS counterattack potentially blocks acquisition of parasitic foreign DNA. However, since we have now demonstrated that some T4SSs pose a more immediate lethal threat to neighbouring bacteria, many bacterial species may have been under much stronger evolutionary pressure to have evolved an automatic T6SS counterattack response. This immediately suggests the hypothesis that, since very few T4SS have been characterized to date, T4SS-mediated bacterial killing may not be restricted to the Xanthomonadaceae family, and may in fact be a more widespread phenomenon.
Bacterial strains, growth conditions and cloning
Bacterial strains, oligonucleotides and plasmids used in this study are described in Supplementary Table 2. All strains were grown on LB or 2 × TY (2 × yeast extract and tryptone) media. Concentrations of the antibiotics used: 100 μg ml−1 ampicilin, 20 μg ml−1 gentamicin, 100 μg ml−1 spectinomycin, 15 μg ml−1 tetracycline, 100 μg ml−1 chloramphenicol and 30 μg ml−1 kanamycin. For generation of the Xac Δxac2609 strain, ~1 kb of the upstream and downstream regions of the xac2609 gene were amplified by PCR from Xanthomonas citri subsp. citri strain 306 genomic DNA and the two fragments were ligated to produce an in-frame deletion, leaving only the region coding for the first 15 and last 12 codons. This sequence was then cloned into the BamHI restriction site of the pNPTS138 suicide vector (M. R. Alley, unpublished; described in Supplementary Table 2), thereby generating the pNPTS138-2609 plasmid. For generation of the Xac ΔvirD4 strain, a DNA fragment including the virD4 gene plus 0.55 kb upstream and downstream sequences were amplified by PCR and cloned into the NdeI/HindIII sites of the pUC19 vector. The resulting pUC19-virD4 vector was digested with the SacI restriction enzyme; as the virD4 gene has three of these sites, the digestion and subsequent re-ligation of the plasmid removed an internal fragment of 0.75 kb of virD4, generating the pUC19-ΔvirD4. This strategy removed 251 codons of the central region of the gene, leaving the first 256 and the last 50 codons of virD4. This plasmid was digested with SpeI/SalI and the resulting DNA containing the virD4 gene fragment plus 0.55 kb upstream and downstream sequences was cloned into the pNPTS138, thereby generating the pNPTS138-virD4 plasmid. In-frame deletions in the virD4 and xac2609 genes were obtained by a two-step allelic exchange procedure as previously described for the virB7 gene21 using the pNPTS138-2609 and pNPTS138-virD4 vectors. For complementation of Xac mutant strains, genes virB7XAC2622, virD4XAC2623 and xac2609 (coding the full-length protein (residues 1–431) or its N-terminal domain (residues 1–306)) were cloned in the pBAD24-derived vector pBRA (M. Marroquin, unpublished; described in Supplementary Table 2), which contains an arabinose-induced promoter that is constitutively active in Xac. Genes virB7, virD4, xac2609 and xac2609Nt were amplified by PCR from Xac306 genomic DNA and PCR products were cloned directly into the NcoI/SalI sites of pBRA. A recombinant XAC2610 (GenBank accession code AAM37459) fragment consisting of residues 22–267 fused to an N-terminal His-tag (X-TfiXAC2610(His-22–267)) and full-length XAC2609 (residues 1–431; X-TfeXAC2609(1–431); GenBank accession code AAM37458) were expressed as described previously20. In brief, DNA coding for residues 55–267 of XAC2610 (X-TfiXAC2610(55–267)) and N terminus (residues 1–308; X-TfeXAC2609(1–308)) and C terminus (residues 311–431; X-TfeXAC2609(311–431)) fragments of XAC2609 were amplified by PCR from Xac genomic DNA and cloned into the pET11a plasmid (Novagen) using the NdeI and BamHI cloning sites. The pET11a-XAC26091–308 vector was used as a DNA template for the generation of the pET11a-XAC2609-E48A plasmid that codes for X-TfeXAC2609(1–308_E48A) (the X-TfeXAC2609(1–308) protein with a Glu 48 to Ala mutation), using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies). DNA coding for the N-terminal fragment of XAC0466 (residues 1–475; X-TfeXAC0466(His-1–475); GenBank accession code AAM35357) was cloned into the pET28a vector using the NdeI and BamHI sites, expressing a protein fused to an N-terminal His-tag. All plasmids were confirmed by DNA sequence analysis.
Protein expression and purification
E. coli BL21(DE3)RP strain (Novagen) was used for the expression of the recombinant proteins. Cells were grown in 2 × TY at 37 °C and recombinant proteins were induced at mid-log phase for 3–4 h by the addition of 0.5 mM isopropyl-β-D-thiogalactoside. Cells were then harvested and lysed by sonication employing a Vibra-Cell VCX-500 instrument (Sonics & Materials Inc.). The first chromatographic purification step was performed with a Q-sepharose anion exchange column (GE Healthcare) for all X-TfeXAC2609 and X-TfiXAC2610 constructions. The second chromatographic step was an affinity purification using a nickel chelate column for X-TfiXAC2610(His-22–267), a size exclusion purification with a 26/600 Superdex 75 column for X-TfiXAC2610(55–267), X-TfeXAC2609(1–308) and X-TfeXAC2609(311–431) or a 26/600 Superdex 200 column for X-TfeXAC2609(1–431) and X-TfeXAC2609(1–308_E48A). X-TfeXAC0466(His-1–475) was purified using a nickel chelate column.
PG hydrolase activity assay
Micrococcus luteus cell wall suspensions (Sigma) with an optical density at 650 nm (OD650 nm) of 0.7 (0.8 mg ml−1) in 50 mM sodium acetate (pH 5.0) and 2 mM CaCl2 were incubated in triplicate for 20 min at 30 °C with the following treatments: (i) without proteins (buffer), (ii) with X-TfiXAC2610(55–267), (iii) X-TfeXAC2609(1–431), (iv) X-TfeXAC2609(1–308), (v) X-TfeXAC2609(1–308_E48A), (vi) X-TfeXAC0466(His-1–475), (vii) HEWL, (viii) X-TfeXAC2609(1–431) plus X-TfiXAC2610(55–267), (ix) X-TfeXAC2609(1–308) plus X-TfiXAC2610(55–267), (x) X-TfeXAC0466(His-1–475) plus X-TfiXAC2610(55–267) or (xi) HEWL plus X-TfiXAC2610(55–267). X-TfeXAC2609-derived proteins, X-TfeXAC0466(His-1–475) and HEWL, were used at 1 μM concentration, while X-TfiXAC2610(55–267) was present at 2 μM. The reactions were stopped with the addition of 500 mM sodium carbonate. Cell wall degradation was monitored as a decrease in OD650 nm.
Bacterial growth inhibition assay
Bacillus subtilis PY79 cells were grown in 2 × TY to log phase (OD600 nm=0.5). Cells were harvested by centrifugation and resuspended to an OD600 nm of 0.8 in 10 mM sodium acetate pH 5.0 and 1 mM MgCl2. Incubations were performed in triplicate for 10 min at 30 °C with only buffer or buffer containing 1 μM X-TfeXAC2609(1–431) or 2 μM X-TfiXAC2610(55–267) or 1 μM X-TfeXAC2609(1–431) plus 2 μM X-TfiXAC2610(55–267). The bacteria were then diluted with nine volumes fresh 2 × TY medium and subsequent growth at 30 °C was monitored by measuring OD600 nm.
Bacillus subtilis lysis by X-Tfes
Bacillus subtilis PY79 cells were grown in LB to OD600 nm=0.5, harvested by centrifugation and resuspended to an OD600 nm of 0.8 in 10 mM sodium acetate (pH 5.0), 1 mM MgCl2. Incubations were performed with only buffer or buffer containing (i) 1 μM X-TfeXAC2609(1–431), (ii) 1 μM X-TfeXAC2609(1–308), (iii) 1 μM X-TfeXAC2609(1–308_E48A), (iv) 2 μM X-TfiXAC2610(55–267), (v) 1 μM X-TfeXAC2609(1–431) plus 2 μM X-TfiXAC2610(55–267), (vi) 1 μM X-TfeXAC2609(1–308) plus 2 μM X-TfiXAC2610(55–267), (vii) 1 μM X-TfeXAC0466(His-1–475) or (viii) 1 μM HEWL. After 5 min of treatment at 23 °C, cells were centrifuged, washed, resuspended in 2 × TY and mounted on slides covered with a layer of 25% LB plus 1.5% agarose. Membranes were stained with FM1-43 or FM5-95 (Molecular Probes) at a final concentration of 1 μg ml−1 and the stained cells were analysed by fluorescence microscopy.
Microscopy was carried out using a Nikon Eclipse Ti microscope equipped with filters for GFP (GFP-3035B-000-ZERO, Semrock), CFP (CFP-2432A-000-ZERO, Semrock), YFP (YFP-2427-000-ZERO, Semrock) and membrane visualization (Texas Red BrightLine set; TXRED4040-B, Semrock), a Plan APO VC Nikon 100 × objective (numerical aperture=1.4), a CFI Plan Apo Lambda Nikon 2 × objective and an Andor EMCCD i-Xon camera. The exposure times varied from 0.2 to 1 s. Images were processed and analysed using the programs Nis Elements (version 3.07; Nikon) and ImageJ (http://rsbweb.nih.gov/ij/).
Antibody production, immunoprecipitation and immunoblot
Rabbit polyclonal antibodies were produced against X-TfeXAC2609(1–431) and X-TfiXAC2610(His-22–267). Xac total cell lysates from WT and ΔvirB7XAC2622 (ΔB7) strains were used for immunoprecipitation experiments with pre-immune serum or anti-X-TfiXAC2610 serum (1:1,000 dilution), followed by immunoblots with anti-X-TfeXAC2609 and anti-X-TfiXAC2610 antibodies (1:1,000 dilution), performed as previously described21. Pre-immune serum, from the same animal later immunized with X-TfiXAC2610, was used as a negative control.
Fluorescence assays were measured employing AVIV ATF-105 and Hitachi F-4500 fluorometers. Qualitative protein–protein interaction assays were carried out using 1 μM protein alone (X-TfiXAC2610(55–267), X-TfeXAC2609(1–431), X-TfeXAC2609(1–308) and X-TfeXAC2609(311–431)) or combinations of X-TfiXAC2610(55–267) and one of the three X-TfeXAC2609 fragments in 20 mM Tris-HCl pH 7.5, 50 mM NaCl, 3 mM EGTA and 4 mM CaCl2. Samples were pre-equilibrated at 25 °C for 2 min, excited at 295 nm (bandwidth of 2.5 nm) and fluorescence emission was recorded from 300 to 400 nm (bandwidth of 2.5 nm) at 0.2-nm intervals. The results of three experiments were averaged.
Crystallization, data collection and processing
Vapour diffusion sitting drop crystallization screens at 18 °C were performed for X-TfiXAC2610(His-22–267), but no crystals were obtained. Two weeks incubation of this protein at room temperature produced an ~23 kDa proteolytic fragment that formed thin needle-like crystals. The N-terminal sequence of this fragment was determined by Edman degradation using a Sequenator model PPSQ-23 (Shimadzu) and MALDI-ToF measurements employing an Ettan MALDI-ToF mass spectrometer (GE Healthcare). The sequence was found to begin at residue 56 and mass spectroscopy analysis was consistent with a fragment consisting of X-TfiXAC2610 residues 55–267. Recombinant X-TfiXAC2610(55–267) protein (400 μM dissolved in 10 mM Tris-HCl pH 7.0, 20 mM NaCl) was submitted to crystallization trials and crystals were observed after 2 weeks over a reservoir solution containing 100 mM Bis-Tris-HCl pH 5.5, 200 mM (NH4)2SO4 and 25% (w/v) PEG3350. Crystals were transferred to reservoir solution supplemented with 20% (v/v) glycerol and flash frozen at 100 K. X-ray diffraction data were collected using an in-house Rigaku MicroMax-007 HF microfocus rotating Cu anode generator (Institute of Chemistry, University of São Paulo) and the beamline W01B-MX2 of the Brazilian Synchrotron Light Laboratory (LNLS)46. The diffraction data were indexed, integrated and scaled using d*TREK47 and HKL2000 (ref. 48). Data collection statistics are shown in Supplementary Table 1.
X-ray structure determination and refinement
The crystal structure of X-TfiXAC2610(55–267) was determined by SIRAS (single isomorphous replacement with anomalous scattering) using crystals soaked for 5 min with reservoir solution supplemented with 20% (v/v) glycerol and a saturated solution of mercury acetate. The initial phase estimation was carried out using SHELXD49 and autoSHARP50, followed by automatic model building by ARP/wARP51. The model was subsequently refined with the program Coot52 with rounds of TLS53 and restrained refinement in Refmac554 from the CCP4 package55. Model quality was checked by Coot, Refmac5, MolProbity56, Rampage57 and PROCHECK58. Clear electron density was visible for all residues except for the first four amino acids (residues 55–58) that were not, therefore, included in the model. The electron density of some specific exposed loops (residues 59–60, 139–143, 218–220 and 245–249) had a relatively lower signal-to-noise level but was sufficient to model their backbones with confidence. A total of 180 water molecules and a calcium ion were also modelled. The final model has Rfactor and Rfree of 0.200 and 0.241, respectively (Supplementary Table 1). Figures were prepared using PYMOL (http://www.pymol.org) and protein topology schemes with TopDraw 59. The coordinates of the X-TfiXAC2610(55–267) X-ray crystal structure were deposited in the PDB under accession code 4QTQ. Search for structural similarities were performed using the Dali server60. The Z-score, root mean squared deviation, number of residues superposed and fraction of the chain for the superposition of X-TfiXAC2610 and Tsi1 are 6.5, 3.4 Å, 120 and 82%, respectively, and for the superposition of X-TfiXAC2610 and PliI are 4.9, 3.7 Å, 95 and 78%.
Small-angle X-ray scattering (SAXS)
SAXS experiments were collected at the D11A-SAXS1 beamline at the LNLS in Brazil. The radiation wavelength was 1.55 Å and a Pilatus detector at 936 mm distance was used to give a scattering vector (q=4π/λsin(θ), where 2θ is the scattering angle) ranging from 0.14 to 4.1 nm−1. X-TfiXAC2610(55–267) at 3.34, 1.67 and 0.84 mg ml−1 dissolved in 20 mM Tris-HCl pH 7.5 and 100 mM NaCl was exposed in frames of 3 and 10 s, and only normalized data without significant radiation damage in the small q range were averaged to give the final scattering curve. Buffer scattering curves were collected and subtracted from the sample’s scattering curve, taking into account its attenuation. The scattering curves were normalized by the protein concentration to check for interference effects61 or aggregation62 over the SAXS curves. Guinier analysis was used to calculate the protein radius of gyration, Rg, and to evaluate the monodispersity of the system. SAXS data analyses were performed using the ATSAS package63. The determination of the pair-distance distribution function, p(r), was conducted using the GNOM software64. After the p(r) calculation, 15 low resolution ab initio envelopes for X-TfiXAC2610(55–267) were generated with DAMMIN65 and aligned and averaged using the program suite DAMAVER66. The normalized spatial discrepancy between the models was 0.562±0.011 and none were rejected. Comparisons of the scattering experimental data and X-ray protein models were performed using CRYSOL67.
X-TfeXAC2609 secretion analysis
GFP-labelled Xac strains (Xac WT pBRA GFP, Xac ΔvirD4 pBRA GFP, Xac ΔvirD4 pBRA-virD4 GFP, Xac ΔvirB7 pBRA GFP, Xac ΔvirB7 pBRA-virB7 GFP, Xac Δ2609 pBRA GFP, Xac Δ2609 pBRA-2609FL GFP and Xac Δ2609 pBRA-2609Nt GFP; Supplementary Table 2) and E. coli BL21(DE3)RIL ArcticExpress were grown separately in 2 × TY to log phase (OD600 nm of 1.0), centrifuged, washed and resuspended to OD600 nm=2.0. Xac strains and E. coli were mixed at a 1:1 ratio. Xac alone or the mixtures (5 μl) were spotted onto a nitrocellulose transfer membrane (GE Healthcare). The filter was placed on LB agar media containing gentamicin and spectinomycin and maintained at 30 °C for 12 h. Cells were washed away with running water for 2 min, the filter was blocked in 10% non-fat milk and then incubated with anti-X-TfeXAC2609 rabbit serum at 1:1,000 dilution. The primary antibody was detected using IRDye 800CW goat anti-rabbit IgG (LI-COR Biosciences) at 1:25,000 dilution. Membranes were scanned using an Odyssey CLx infrared imaging system (LI-COR Biosciences). Integrated fluorescence intensities with median background subtracted were quantified using the Image Studio Lite (version 4.0) software package, normalized to the values measured for the WT Xac:E. coli mixture, and the results from seven independent experiments averaged. Western blots of total cellular X-TfeXAC2609 produced by the Xac strains were carried out with the same antibodies and documented using an Odyssey detection system as described above.
Xanthomonas growth in liquid and solid media
For analysis of Xac cell growth in liquid medium, the Xac WT, ΔvirB7 and ΔvirD4 strains were inoculated in triplicate in 2 × TY medium with a starting OD600 nm of 0.05, grown for 2 days at 30 °C with agitation at 200 r.p.m. and the cell growth was monitored by measuring OD600 nm and colony-forming unit (CFU) per ml at different time intervals. For analysis of cell growth on solid medium, 2.5 μl of Xac WT, ΔvirB7 and ΔvirD4 strains at OD600 nm of 0.05 were plated onto LB agar medium. Colonies were resuspended in 1 ml of 2 × TY after 32, 53 and 74 h of growth and serial dilutions were plated on LB agar for CFU count.
Interbacterial growth competition experiments
Assays were performed in a manner similar to that described previously7,33. In brief, CFP-labelled Xac strains (Xac WT pUFR CFP, Xac ΔvirB7 pUFR CFP and Xac ΔvirB7 pUFR-virB7 CFP) and E. coli DH5α YFP (Supplementary Table 2) were grown in 2 × TY to log phase (OD600 nm=1.0), centrifuged, washed and resuspended to OD600 nm=0.5. These Xac cells were then mixed with E. coli diluted at an 80:1 Xac:E. coli ratio. The mixtures were spotted on LB agar plates containing gentamicin and allowed to grow together as a co-culture at 30 °C. Fluorescence micrographs were collected after 48 h of incubation. Competition experiments of Xac cells (Xac WT GFP, Xac ΔvirB7 GFP and Xac ΔvirD4 GFP; Supplementary Table 2) against C. violaceum were performed as above without antibiotic selection and analysed after 24 h of incubation. The results of competition experiments were quantified by determining the CFU of Xac and E. coli per colony of a co-culture initiated with a 180:1 Xac:E. coli mixture in which the initial Xac OD600 nm=0.05. Xac strains used were Xac WT pUFR, Xac ΔvirB7 pUFR and Xac ΔvirB7 pUFR-virB7 and the E. coli strain was E. coli BL21(DE3)RIL ArcticExpress. Final Xac:E. coli ratios were calculated after 38 h of competition by resuspending the colony, performing serial dilution and plating the cells in LB agar media containing tetracycline for selection of E. coli and ampicillin for selection of Xac.
Contact-dependent bacterial competition assays
GFP-labelled Xac strains (Xac WT pBRA GFP, Xac ΔvirD4 pBRA GFP, Xac ΔvirD4 pBRA-virD4 GFP, Xac ΔvirB7 pBRA GFP and Xac ΔvirB7 pBRA-virB7 GFP; Supplementary Table 2) and E. coli BL21(DE3)RIL ArcticExpress were grown in 2 × TY to OD600 nm=1.0, collected by centrifugation, washed and resuspended to OD600 nm=2.0. Xac strains and E. coli were mixed at a 1:1 ratio. Xac alone or the mixtures were spotted onto a 0.22 μm polycarbonate membrane (Whatman) placed on LB agar plates containing gentamicin and spectinomycin and the gfp fluorescence emission from the Xac cells was documented after 24 h growth at 30 °C. In parallel, no-contact experiments were carried out by growing Xac cells on an intervening filter placed on top of an E. coli BL21(DE3)RIL ArcticExpress lawn grown on LB agar plates containing gentamicin and spectinomycin. The intervening filter prevents direct contact between Xac and E. coli cells.
Microscopy analysis of Xac vs E. coli competition assays
Xac strains (Xac WT pUFR CFP, Xac ΔvirB7 pUFR CFP and Xac ΔvirB7 pUFR-virB7 CFP or Xac WT pBRA GFP, Xac ΔvirD4 pBRA GFP and Xac ΔvirD4 pBRA-virD4 GFP; see Supplementary Table 2) and E. coli cells (DH5α YFP or BL21(DE3)RIL ArcticExpress) were grown in 2 × TY with appropriate antibiotics to OD600 nm=1.0, centrifuged, washed, resuspended to OD600 nm=2.0, mixed at a Xac:E. coli 1:1 ratio and 2 μl spotted onto an LB agarose pad (1.5% agarose in 25% LB medium). Interspecies competition was followed by fluorescence and brightfield microscopy. Brightfield time-lapse data were acquired every 0.3 s. Image analysis and movie edition were performed using ImageJ software, and Supplementary Movie 1 was processed at 20 frames per second (that is, each second of the movie is equivalent to 6 s of the experiment).
Accession codes X-ray crystallographic coordinates and structure factors for X-TfiXAC2610 have been deposited in the Protein Data Bank with accession code 4QTQ.
How to cite this article: Souza, D. P. et al. Bacterial killing via a Type IV secretion system. Nat. Commun. 6:6453 doi: 10.1038/ncomms7453 (2015).
Burkinshaw, B. J. & Strynadka, N. C. Assembly and structure of the T3SS. Biochim. Biophys. Acta. 1843, 1649–1663 (2014) .
Alvarez-Martinez, C. E. & Christie, P. J. Biological diversity of prokaryotic type IV secretion systems. Microbiol. Mol. Biol. Rev. 73, 775–808 (2009) .
Silverman, J. M., Brunet, Y. R., Cascales, E. & Mougous, J. D. Structure and regulation of the type VI secretion system. Annu. Rev. Microbiol. 66, 453–472 (2012) .
Nivaskumar, M. & Francetic, O. Type II secretion system: a magic beanstalk or a protein escalator. Biochim. Biophys. Acta. 1843, 1568–1577 (2014) .
van Ulsen, P., Rahman, S., Jong, W. S., Daleke-Schermerhorn, M. H. & Luirink, J. Type V secretion: from biogenesis to biotechnology. Biochim. Biophys. Acta. 1843, 1592–1611 (2014) .
Hayes, C. S., Koskiniemi, S., Ruhe, Z. C., Poole, S. J. & Low, D. A. Mechanisms and biological roles of contact-dependent growth inhibition systems. Cold Spring Harb. Perspect Med. 4, a010025 (2014) .
Hood, R. D. et al. A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria. Cell. Host. Microbe. 7, 25–37 (2010) .
Backert, S. & Meyer, T. F. Type IV secretion systems and their effectors in bacterial pathogenesis. Curr. Opin. Microbiol. 9, 207–217 (2006) .
Dehio, C. Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction. Cell. Microbiol. 10, 1591–1598 (2008) .
Locht, C., Coutte, L. & Mielcarek, N. The ins and outs of pertussis toxin. FEBS J. 278, 4668–4682 (2011) .
de Jong, M. F. & Tsolis, R. M. Brucellosis and type IV secretion. Future Microbiol. 7, 47–58 (2012) .
Tegtmeyer, N., Wessler, S. & Backert, S. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J. 278, 1190–1202 (2011) .
Ge, J. & Shao, F. Manipulation of host vesicular trafficking and innate immune defence by Legionella Dot/Icm effectors. Cell. Microbiol. 13, 1870–1880 (2011) .
Hofreuter, D., Odenbreit, S. & Haas, R. Natural transformation competence in Helicobacter pylori is mediated by the basic components of a type IV secretion system. Mol. Microbiol. 41, 379–391 (2001) .
Hamilton, H. L., Dominguez, N. M., Schwartz, K. J., Hackett, K. T. & Dillard, J. P. Neisseria gonorrhoeae secretes chromosomal DNA via a novel type IV secretion system. Mol. Microbiol. 55, 1704–1721 (2005) .
Pitzschke, A. & Hirt, H. New insights into an old story: Agrobacterium-induced tumour formation in plants by plant transformation. EMBO J. 29, 1021–1032 (2010) .
Low, H. H. et al. Structure of a type IV secretion system. Nature 508, 550–553 (2014) .
Waksman, G. & Orlova, E. V. Structural organisation of the type IV secretion systems. Curr. Opin. Microbiol. 17, 24–31 (2014) .
Trokter, M., Felisberto-Rodrigues, C., Christie, P. J. & Waksman, G. Recent advances in the structural and molecular biology of type IV secretion systems. Curr. Opin. Struct. Biol. 27, 16–23 (2014) .
Alegria, M. C. et al. Identification of new protein-protein interactions involving the products of the chromosome- and plasmid-encoded type IV secretion loci of the phytopathogen Xanthomonas axonopodis pv. citri. J. Bacteriol. 187, 2315–2325 (2005) .
Souza, D. P. et al. A component of the Xanthomonadaceae type IV secretion system combines a VirB7 motif with a N0 domain found in outer membrane transport proteins. PLoS Pathog. 7, e1002031 (2011) .
Frederiksen, R. F. et al. Bacterial chitinases and chitin-binding proteins as virulence factors. Microbiology. 159, 833–847 (2013) .
Russell, A. B. et al. Type VI secretion delivers bacteriolytic effectors to target cells. Nature 475, 343–347 (2011) .
Russell, A. B. et al. Diverse type VI secretion phospholipases are functionally plastic antibacterial effectors. Nature 496, 508–512 (2013) .
Van Herreweghe, J. M. et al. Lysozyme inhibitor conferring bacterial tolerance to invertebrate type lysozyme. Cell. Mol. Life Sci. 67, 1177–1188 (2010) .
Leysen, S. et al. Molecular basis of bacterial defense against host lysozymes: X-ray structures of periplasmic lysozyme inhibitors PliI and PliC. J. Mol. Biol. 405, 1233–1245 (2011) .
Ding, J., Wang, W., Feng, H., Zhang, Y. & Wang, D. C. Structural insights into the Pseudomonas aeruginosa type VI virulence effector Tse1 bacteriolysis and self-protection mechanisms. J. Biol. Chem. 287, 26911–26920 (2012) .
Fronzes, R. et al. Structure of a type IV secretion system core complex. Science 323, 266–268 (2009) .
Basler, M., Ho, B. T. & Mekalanos, J. J. Tit-for-tat: type VI secretion system counterattack during bacterial cell-cell interactions. Cell 152, 884–894 (2013) .
LeRoux, M. et al. Quantitative single-cell characterization of bacterial interactions reveals type VI secretion is a double-edged sword. Proc. Natl Acad. Sci. USA 109, 19804–19809 (2012) .
MacIntyre, D. L., Miyata, S. T., Kitaoka, M. & Pukatzki, S. The Vibrio cholerae type VI secretion system displays antimicrobial properties. Proc. Natl Acad. Sci. USA 107, 19520–19524 (2010) .
Murdoch, S. L. et al. The opportunistic pathogen Serratia marcescens utilizes type VI secretion to target bacterial competitors. J. Bacteriol. 193, 6057–6069 (2011) .
Schwarz, S. et al. Burkholderia type VI secretion systems have distinct roles in eukaryotic and bacterial cell interactions. PLoS Pathog. 6, e1001068 (2010) .
Casas-Godoy, L., Duquesne, S., Bordes, F., Sandoval, G. & Marty, A. Lipases: an overview. Methods Mol. Biol. 861, 3–30 (2012) .
Lovering, A. L., Safadi, S. S. & Strynadka, N. C. Structural perspective of peptidoglycan biosynthesis and assembly. Annu. Rev. Biochem. 81, 451–478 (2012) .
Li, G., Miller, A., Bull, H. & Howard, S. P. Assembly of the type II secretion system: identification of ExeA residues critical for peptidoglycan binding and secretin multimerization. J. Bacteriol. 193, 197–204 (2011) .
Scheurwater, E., Reid, C. W. & Clarke, A. J. Lytic transglycosylases: bacterial space-making autolysins. Int. J. Biochem. Cell Biol. 40, 586–591 (2008) .
Firczuk, M. & Bochtler, M. Folds and activities of peptidoglycan amidases. FEMS Microbiol. Rev. 31, 676–691 (2007) .
Wohlkonig, A., Huet, J., Looze, Y. & Wintjens, R. Structural relationships in the lysozyme superfamily: significant evidence for glycoside hydrolase signature motifs. PLoS One 5, e15388 (2010) .
Anantharaman, V. & Aravind, L. Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome. Biol. 4, R11 (2003) .
Mutschler, H., Gebhardt, M., Shoeman, R. L. & Meinhart, A. A novel mechanism of programmed cell death in bacteria by toxin-antitoxin systems corrupts peptidoglycan synthesis. PLoS Biol. 9, e1001033 (2011) .
Zhang, D., Iyer, L. M. & Aravind, L. A novel immunity system for bacterial nucleic acid degrading toxins and its recruitment in various eukaryotic and DNA viral systems. Nucleic Acids Res. 39, 4532–4552 (2011) .
Zhang, D., de Souza, R. F., Anantharaman, V., Iyer, L. M. & Aravind, L. Polymorphic toxin systems: comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics. Biol. Direct. 7, 18 (2012) .
Salomon, D. et al. Marker for type VI secretion system effectors. Proc. Natl Acad. Sci. USA 111, 9271–9276 (2014) .
Ho, B. T., Basler, M. & Mekalanos, J. J. Type 6 secretion system-mediated immunity to type 4 secretion system-mediated gene transfer. Science 342, 250–253 (2013) .
Guimaraes, B. G. et al. The MX2 macromolecular crystallography beamline: a wiggler X-ray source at the LNLS. J. Synchrotron Radiat. 16, 69–75 (2009) .
Pflugrath, J. W. The finer things in X-ray diffraction data collection. Acta. Crystallogr. D Biol. Crystallogr. 55, 1718–1725 (1999) .
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997) .
Sheldrick, G. M. A short history of SHELX. Acta. Crystallogr. A 64, 112–122 (2008) .
Vonrhein, C., Blanc, E., Roversi, P. & Bricogne, G. Automated structure solution with autoSHARP. Methods Mol. Biol. 364, 215–230 (2007) .
Langer, G., Cohen, S. X., Lamzin, V. S. & Perrakis, A. Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat. Protoc. 3, 1171–1179 (2008) .
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta. Crystallogr. D Biol. Crystallogr. 66, 486–501 (2010) .
Painter, J. & Merritt, E. A. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta. Crystallogr. D Biol. Crystallogr. 62, 439–450 (2006) .
Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta. Crystallogr. D Biol. Crystallogr. 67, 355–367 (2011) .
Collaborative Computational Project Number 4. The Ccp4 suite - programs for protein crystallography. Acta. Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994) .
Davis, I. W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375–W383 (2007) .
Lovell, S. C. et al. Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins 50, 437–450 (2003) .
Laskowski, R. A., Macarthur, M. W., Moss, D. S. & Thornton, J. M. Procheck - a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–291 (1993) .
Bond, C. S. TopDraw: a sketchpad for protein structure topology cartoons. Bioinformatics 19, 311–312 (2003) .
Holm, L. & Rosenstrom, P. Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545–W549 (2010) .
Barbosa, L. R. et al. The importance of protein-protein interactions on the pH-induced conformational changes of bovine serum albumin: a small-angle X-ray scattering study. Biophys. J. 98, 147–157 (2010) .
Jacques, D. A. & Trewhella, J. Small-angle scattering for structural biology--expanding the frontier while avoiding the pitfalls. Protein Sci. 19, 642–657 (2010) .
Petoukhov, M. V. et al. New developments in the ATSAS program package for small-angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350 (2012) .
Svergun, D. I. Determination of the regularization parameter in indirect-transform methods using perceptual criteria. J. Appl. Crystallogr. 25, 495–503 (1992) .
Svergun, D. I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879–2886 (1999) .
Volkov, V. V. & Svergun, D. I. Uniqueness of ab initio shape determination in small-angle scattering. J. Appl. Crystallogr. 36, 860–864 (2003) .
Svergun, D., Barberato, C. & Koch, M. H. J. CRYSOL - A program to evaluate x-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28, 768–773 (1995) .
Babu, M. M. et al. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J. Bacteriol. 188, 2761–2773 (2006) .
da Silva, A. C. et al. Comparison of the genomes of two Xanthomonas pathogens with differing host specificities. Nature 417, 459–463 (2002) .
Marchler-Bauer, A. et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic Acids Res. 39, D225–D229 (2011) .
We thank Dr Frederico Gueiros-Filho for support in the microscopy studies and the Brazilian Synchrotron Light Laboratory (LNLS) and the Central Analítica (Instituto de Química, USP) for providing access to the X-ray beamlines. We thank Germán Sgro and Miryam Marroquin for the kind gift of plasmids pBBR-5YFP and pBRA, respectively and thank Cassia Docena for help in producing the virD4 knockout. This work was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) to C.S.F. (# 2007/59425-0, 2005/59243-3, 2009/54009-3 and 2011/07777-5), FAPESP fellowships to D.P.S., A.W.B-F., C.E.A-M., G.D. and C.R.G., and CAPES fellowships to D.P.S., A.W.B-F. and G.U.O. C.S.F and L.R.S.B thank CNPq for the financial support.
The authors declare no competing financial interests.
Supplementary Figures 1-9, Supplementary Tables 1-2 and Supplementary References (PDF 3200 kb)
Supplementary Movie 1
Time-lapse microscopy of Xac and E. coli co-cultures on a thin agarose surface. The first part of the film shows three different fields containing wild type Xac cells expressing cfp (cyan) and E. coli DH5α expressing yfp (yellow). The middle part shows three fields of cfp-expressing Xac ΔvirB7 strain carrying a plasmid for VirB7 expression (cyan) and E. coli DH5α yfp (yellow). The last part shows gfp-expressing Xac ΔvirD4 strain carrying a plasmid for VirD4 expression (green) and non-fluorescent E. coli BL21(DE3)RIL ArcticExpress cells. White arrows point to E. coli cells that undergo lysis. Images were recorded at 300 ms intervals and the movie is sped up 6 times. (MOV 2000 kb)
Rights and permissions
About this article
Cite this article
Souza, D., Oka, G., Alvarez-Martinez, C. et al. Bacterial killing via a type IV secretion system. Nat Commun 6, 6453 (2015). https://doi.org/10.1038/ncomms7453
This article is cited by
The evolutionary origin of host association in the Rickettsiales
Nature Microbiology (2022)
Microbiota-mediated colonization resistance: mechanisms and regulation
Nature Reviews Microbiology (2022)
Pseudomonas putida mediates bacterial killing, biofilm invasion and biocontrol with a type IVB secretion system
Nature Microbiology (2022)
Architecture of the outer-membrane core complex from a conjugative type IV secretion system
Nature Communications (2021)
Unlocking the bacterial contact-dependent antibacterial activity to engineer a biocontrol alliance of two species from natural incompatibility to artificial compatibility
Stress Biology (2021)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.